Aprea Investors
Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.
Founded Date:
2003
Industry:
P4 Medicine
Headquarters:
Stockholm, Stockholms Lan, Sweden
Investor Type:
Healthcare Company
Employee Number:
11-50